These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1838237)

  • 1. [Advanced cancer of the exocrine pancreas treated by a long-acting luteinising hormone releasing hormone (LH-RH) analogue, triptorelin: phase II study].
    François E; Lagrange JL; Benchimol D; Hebuterne X; Montoya ML; Fratini G; Rampal P; Richelme H; Namer M
    Ann Chir; 1991; 45(10):909-11. PubMed ID: 1838237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to D-Trp-6-LH-RH in advanced adenocarcinoma of pancreas.
    Gonzalez-Barcena D; Rangel-Garcia NE; Perez-Sanchez PL; Gutierrez-Damperio C; Garcia-Carrasco F; Comaru-Schally AM; Schally AV
    Lancet; 1986 Jul; 2(8499):154. PubMed ID: 2873411
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of D-Trp-6-LH-RH on the survival time in patients with advanced pancreatic cancer.
    González-Barcena D; Ibarra-Olmos MA; García-Carrasco F; Gutiérrez-Samperio C; Comaru-Schally AM; Schally AV
    Biomed Pharmacother; 1989; 43(4):313-7. PubMed ID: 2529000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists.
    Szende B; Srkalovic G; Groot K; Lapis K; Schally AV
    Cancer Res; 1990 Jun; 50(12):3716-21. PubMed ID: 2160323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LH-RH agonists in the treatment of pancreatic cancer.
    Gonzalez-Barcena D
    Recent Results Cancer Res; 1992; 124():105-12. PubMed ID: 1535448
    [No Abstract]   [Full Text] [Related]  

  • 6. [Contribution to studies on the treatment of cancer of the prostate with D-Trp6-LH-RH].
    Marcellino LR; Campanella A; Bandini M
    Biomed Pharmacother; 1987; 41(9-10):468-72. PubMed ID: 2968123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin.
    Szende B; Zalatnai A; Schally AV
    Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1643-7. PubMed ID: 2564204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LH-RH analogue treatment in adenocarcinoma of the pancreas: a phase II study. Gruppo Ligure per lo Studio del Pancreas.
    Allegretti A; Lionetto R; Saccomanno S; Paganuzzi M; Onetto M; Martinoli C; Rollandi G; Marugo M; Fazzuoli L; Pugliese V
    Oncology; 1993; 50(2):77-80. PubMed ID: 8451039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160. Histological evidence of improvement.
    Zalatnai A; Schally AV
    Int J Pancreatol; 1989 Mar; 4(2):149-60. PubMed ID: 2566638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of N-nitrosobis(2-oxopropyl)amine-induced pancreatic cancer in Syrian golden hamsters with D-Trp-6-LH-RH and somatostatin analogue RC-160 microcapsules.
    Zalatnai A; Schally AV
    Cancer Res; 1989 Apr; 49(7):1810-5. PubMed ID: 2564312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer.
    Parmar H; Rustin G; Lightman SL; Phillips RH; Hanham IW; Schally AV
    Br Med J (Clin Res Ed); 1988 Apr; 296(6631):1229. PubMed ID: 2968130
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy and safety of long-acting gonadotropin-releasing hormone analogue in the treatment for metastatic prostate cancer].
    Li NC; Song Y; Jiang HW; Ding Q; Gan WD; Guo HQ; Sun ZY; Hu ZQ; Ye ZQ; Wei Q; Na YQ
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1653-7. PubMed ID: 19094763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with an LHRH analogue in patients with advanced pancreatic cancer. A preliminary report.
    Andrén-Sandberg A
    Acta Chir Scand; 1990 Aug; 156(8):549-51. PubMed ID: 2146849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of adenocarcinoma of the pancreas with somatostatin and gonadoliberin (luteinizing hormone-releasing hormone). The French Associations for Surgical Research.
    Huguier M; Samama G; Testart J; Mauban S; Fingerhut A; Nassar J; Houry S; Jaeck D; De Mestier P; Favre JP
    Am J Surg; 1992 Oct; 164(4):348-53. PubMed ID: 1357998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The luteinising hormone-releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers.
    Martinetti A; Ferrari L; Celio L; Mariani L; Miceli R; Zilembo N; Di Bartolomeo M; Toffolatti L; Pozzi P; Seregni E; Bombardieri E; Bajetta E
    J Steroid Biochem Mol Biol; 2000 Dec; 75(1):65-73. PubMed ID: 11179910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the chronic administration of LH-RH agonist on the oral glucose tolerance test in patients with prostatic carcinoma.
    González-Bárcena D; Pérez-Sánchez P; Hernández-Meza AR; Rangel-García N; Graef-Sánchez A; Comaru-Schally AM; Schally AV
    Arch Invest Med (Mex); 1987; 18(4):273-8. PubMed ID: 2969222
    [No Abstract]   [Full Text] [Related]  

  • 17. How would you like to have an orchidectomy for advanced prostatic cancer?
    Parmar H; Phillips RH; Lightman SL; Edwards L
    Am J Clin Oncol; 1988; 11 Suppl 2():S160-8. PubMed ID: 2977271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic carcinoma of the prostate in both testes of patients treated with LH-RH analogues.
    Hadjissotiriou GG; Papadopoulos S; Rebelakos A
    Br J Urol; 1992 Jun; 69(6):657-9. PubMed ID: 1386273
    [No Abstract]   [Full Text] [Related]  

  • 19. [An analog of gonadoliberin in the treatment of prostatic carcinoma].
    Mathé G; Schally AV; Vo Van ML; Duchier J; Misset JL; Keiling R
    Presse Med; 1984 Jun; 13(23):1443-5. PubMed ID: 6233591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systematic inhibition of the luteinizing hormone with a gonadoliberin analog, triptorelin, during ovarian stimulation for fertilization in vitro. Choice of protocol].
    Fenichel P; Grimaldi M; Hieronimus S; Olivero JF; Donzeau A; Benoit B; Fiorentini M; Tran DK; Harter M; Gillet JY
    Presse Med; 1988 Apr; 17(15):719-22. PubMed ID: 2968548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.